Moreover, dysregulation of the immune response in patients with BPH/LUTS-ED can be through the high expression of IL-17 that stimulates the production of IL-6, which contributes to stromal growth in BPH9. This evidence concerns the gene IL6 and benign prostatic hyperplasia.